£61.25

The Moss Report - Acute Myelogenous Leukemia (AML) Treatment Guide

Price data last checked 60 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£61 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 31 days · 31 data points (no recent data)

Historical
Generating forecast…
£61.25 £58.19 £59.41 £60.64 £61.86 £63.09 £64.31 13 May 2026 20 May 2026 28 May 2026 04 June 2026 12 June 2026

Price Distribution

Price distribution over 31 days • 1 price levels

Days at Price
31 days 0 8 16 23 31 £61 Days at Price

Price Analysis

Most common price: £61 (31 days, 100.0%)

Price range: £61 - £61

Price levels: 1 different prices over 31 days

Description

Ralph W. Moss, PhD, author of Questioning Chemotherapy and The Cancer Industry, has been the go-to authority for patients and practitioners seeking to clarify and understand the various treatment options for different cancer diagnoses for the past 50 years. This guide is the culmination of Dr. Moss’ research and thoughtful consideration of all treatment options for AML. The Moss Report - Acute Myelogenous Leukemia (AML) Treatment Guide provides his unique perspective with clear language around complex topics. Each guide offers a comprehensive examination of conventional treatment options, detailing their effectiveness, potential side effects, and what patients can expect during their journey. Understanding a diagnosis, its causes, and available treatments is vital for making informed decisions. The Moss Report - Acute Myelogenous Leukemia (AML) Treatment Guide Treatment Guide is an indispensable tool, equipping you with the knowledge and confidence to navigate the complexities of cancer treatment and care. Empower yourself to make informed decisions about your cancer treatment journey with the guidance of a seasoned expert who believes in your ability to be a discerning advocate for your health.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
12 January 2024
Listed Since
15 January 2024

Barcode

No barcode data available

Similar Products You Might Like

The Moss Report - Chronic Myeloid Leukemia (CML) Treatment Guide
96% match

The Moss Report - Chronic Myeloid Leukemia (CML) Treatment Guide

£61.24 16 Jun 2026
The Moss Report - Multiple Myeloma Treatment Guide
86% match

The Moss Report - Multiple Myeloma Treatment Guide

£62.28 10 Aug 2026
The Moss Report - Bone Sarcoma Treatment Guide
85% match

The Moss Report - Bone Sarcoma Treatment Guide

£61.25 13 Jun 2026
The Moss Report - Follicular Lymphoma (NHL) Treatment Guide
85% match

The Moss Report - Follicular Lymphoma (NHL) Treatment Guide

£61.45 11 Jun 2026
The Moss Report - Cancer of the Thymus Treatment Guide
84% match

The Moss Report - Cancer of the Thymus Treatment Guide

£61.25 12 Jun 2026
The Moss Report - Skin Cancer: Basal Cell Carcinoma Treatment Guide
83% match

The Moss Report - Skin Cancer: Basal Cell Carcinoma Treatment Guide

£62.40 10 Aug 2026
Treatment of Leukemia and Lymphoma
79% match

Treatment of Leukemia and Lymphoma

Academic Press

£175.00 05 Aug 2026
Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML
79% match

Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML

CREATESPACE

£32.58 05 Aug 2026
Myelodysplastic Syndromes: Diagnosis - Prognosis - Therapy (Hematologic Malignancies)
78% match

Myelodysplastic Syndromes: Diagnosis - Prognosis - Therapy (Hematologic Malignancies)

Springer

£73.13 31 Jul 2026
Bridging the Divide: Translating Biology into Therapeutic Advances in Acute Myeloid leukemia (AML)
78% match

Bridging the Divide: Translating Biology into Therapeutic Advances in Acute Myeloid leukemia (AML)

£96.76 08 Aug 2026
Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)
78% match

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Humana

£95.74 06 Aug 2026
Childhood Acute Lymphoblastic Leukemia
78% match

Childhood Acute Lymphoblastic Leukemia

Springer

£92.00 06 Aug 2026
Diagnóstico y tratamiento de la leucemia linfoblástica aguda
78% match

Diagnóstico y tratamiento de la leucemia linfoblástica aguda

£67.00 30 Jun 2026
Invasive Mykosen bei Patienten mit akuter myeloischer Leukämie: Inzidenz, Letalität und Analyse der Diagnosekriterien der European Organization for Research and Treatment of Cancer
78% match

Invasive Mykosen bei Patienten mit akuter myeloischer Leukämie: Inzidenz, Letalität und Analyse der Diagnosekriterien der European Organization for Research and Treatment of Cancer

£45.00 29 Jun 2026
Multiple Myeloma: Diagnosis and Treatment
77% match

Multiple Myeloma: Diagnosis and Treatment

Springer

£74.21 08 Aug 2026
Handbook of Leukemia
77% match

Handbook of Leukemia

Hayle Medical

£77.17 06 Aug 2026
The Myelodysplastic Syndromes
77% match

The Myelodysplastic Syndromes

Springer

£112.68 04 Aug 2026
Chronic Myeloproliferative Disorders
77% match

Chronic Myeloproliferative Disorders

CRC Press

£145.99 06 Aug 2026
Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide
77% match

Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide

Springer

£98.27 08 Aug 2026
Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium: 108 (Cancer Treatment and Research, 108)
77% match

Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium: 108 (Cancer Treatment and Research, 108)

Springer

£113.76 29 Jun 2026
Biologic Therapy of Leukemia (Contemporary Hematology)
76% match

Biologic Therapy of Leukemia (Contemporary Hematology)

Humana

£73.10 15 Jun 2026
First line therapy in Multiple Myeloma: Overview of recent therapy in treatment of new Multiple Myeloma patients
76% match

First line therapy in Multiple Myeloma: Overview of recent therapy in treatment of new Multiple Myeloma patients

LAP Lambert Academic Publishing

£51.00 01 Jul 2026
Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies
76% match

Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies

Springer

£88.07 05 Aug 2026
Multiple Myeloma - a New Era of Treatment Strategies
76% match

Multiple Myeloma - a New Era of Treatment Strategies

£85.29 10 Aug 2026